Sartorius Stedim Biotech S.A.
SDMHF
$235.80
$0.800.34%
OTC PK
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | 0.16% | -5.83% | -10.20% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 0.16% | -5.83% | -10.20% | |
| Cost of Revenue | -- | -0.66% | 3.42% | 4.26% | |
| Gross Profit | -- | 1.24% | -16.25% | -24.80% | |
| SG&A Expenses | -- | 4.36% | 6.95% | 7.21% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | 139.68% | -557.97% | -333.19% | |
| Total Operating Expenses | -- | 3.90% | 1.73% | 1.21% | |
| Operating Income | -- | -17.71% | -33.71% | -44.18% | |
| Income Before Tax | -- | -46.98% | -58.91% | -68.09% | |
| Income Tax Expenses | -- | -55.54% | -46.82% | -60.81% | |
| Earnings from Continuing Operations | -- | -44.53% | -62.04% | -70.10% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -42.08% | -7.06% | -2.80% | |
| Net Income | -- | -45.18% | -62.62% | -70.56% | |
| EBIT | -- | -17.71% | -33.71% | -44.18% | |
| EBITDA | -- | -5.96% | -20.41% | -28.14% | |
| EPS Basic | -- | -47.75% | -63.94% | -71.37% | |
| Normalized Basic EPS | -- | -17.49% | -76.87% | -76.87% | |
| EPS Diluted | -- | -47.75% | -63.94% | -71.37% | |
| Normalized Diluted EPS | -- | -17.49% | -76.87% | -76.87% | |
| Average Basic Shares Outstanding | -- | 4.92% | 3.64% | 2.52% | |
| Average Diluted Shares Outstanding | -- | 4.92% | 3.64% | 2.52% | |
| Dividend Per Share | -- | -0.98% | -49.51% | -49.51% | |
| Payout Ratio | -- | -0.07% | 0.36% | 0.72% | |